Investors
Icade Santé is now Praemia HEALTHCARE
Following the announcement on July 5, 2023, regarding Primonial REIM's acquisition of 64% of the shares held by Icade in Icade Santé for a total amount of 1.4 billion Euros, the real estate investment company Icade Santé has been renamed Praemia HEALTHCARE.
Status Praemia HEALTHCARE as of july 2023 - in french only
Status Praemia HEALTHCARE as of july 2023 - in french only
Fraud Alert
Stay Vigilant
Praemia HEALTHCARE would like to inform you about the existence of fraudulent solicitations carried out by individuals impersonating Praemia Healthcare.
Below is the history of regulated information
Regulated Information
Document
![]()
Successful launch of Praemia Healthcare’s inaugural sustainable bond issue
Document
![]()
Icade Santé- Résultats 2022 - Rapport Audit Comptes Annuels (FR only)
Document
![]()
Icade Santé - Résultats 2021 - Rapport Audit Comptes Annuels (FR only)
Document
![]()
Statutory Auditors’ review report on the condensed half-year consolidated financial statements - Jan to June 2023
Document
![]()
Half Year 2023 Results
Document
![]()
Icade and Primonial REIM sign an exclusivity agreement for the acquisition of Icade's stake in Icade Santé
Document
![]()
Icade Santé - 2022 Full Year Results
Document
![]()
Half Year 2022 Results
Document
![]()
Icade Santé adds to its portfolio in Spain and completes the sale of four healthcare facilities in France
Document
![]()
New appointment at Icade Santé: Laurent Poinsard named General Secretary
Document
![]()
Opportunistic sale of four healthcare facilities in France for €78m & Ongoing optimisation of the balance sheet
Document
![]()
Icade Santé - 2021 Full Year Results
Document
![]()
Icade Santé invests again in Spain by acquiring an eye clinic in Madrid for €13M
Document
![]()
Icade Santé acquires a portfolio of four private hospital properties in Portugal for €213M
Document
![]()
Icade Santé continues to expand into Germany with ORPEA
Document
![]()
Icade's Healthcare Property Investment Division: First-ever investment in acute care in Italy for €85M and further expansion into long-term care in Germany and Italy alongside KOS
Document
![]()
Icade Santé continues to grow with two acquisitions for €68M
Document
![]()
Postponement of Icade Santé’s IPO
Document
![]()
Announcement on Icade Santé's IPO
Document
![]()
IPO Launch
Load next
Long-term market financing (France scope)
| LONG-TERM RATING | BBB |
| SHORT-TERM RATING | A2 |
| PERSPECTIVE | Stable |
| SINCE | July 2023 |
Praemia HEALTHCARE is an issuer in the Euro bond market, providing a source of diversification.
Bond Holders' General Meeting
Publications & Financial Reports
Document
![]()
Praemia HEALTHCARE Final Prospectus
Document
![]()
Condensed consolidated financial statements as of June 30, 2023
Document
![]()
Condensed consolidated financial statements as of June 30, 2023
Document
![]()
Icade Santé - 2022 Consolidated Financial Statements
Document
![]()
Combined Financial Statements H1 2022 - Healthcare Property Investment Division
Document
![]()
Icade Santé - Condensed consolidated financial statements as of June 30, 2022
Document
![]()
Icade Santé - 2021 Consolidated Financial Statements
Document
![]()
Icade Santé’s first annual Social Bond report (2021)
Document
![]()
Condensed consolidated financial statements as of June 30, 2021
Document
![]()
Consolidated financial statements 2020
Document
![]()
Investor Presentation - Icade Santé Social Bond
Document
![]()
Icade Santé - Social Bond Final Prospectus
Document
![]()
Icade Santé Social Bond Framework Second-Party Opinion
Document
![]()
Icade Santé’s Social Bond framework (September 2020)
Document
![]()
Investor Presentation - Icade Santé - Deal Roadshow (october 2019)
Document
![]()
Icade Santé - Final Prospectus
Document
![]()
Icade Santé - consolidated financial statements as of december 31, 2018, 2017 and 2016
Document
![]()
Condensed consolidated financial statements as of June 30,2019
Load next
et Firefox 
